Vikash Chandra

PI @ Faculty of Medicine, University of Helsinki, Finland

[Vikash Chandra @Dr_V_Chandra]

Honoured to receive support from #diabetestutkimus, #diabetefi for our ongoing #diabetesresearch @HelsinkiUniMed

[Vikash Chandra @Dr_V_Chandra]

Job alert...join us
https://t.co/EZzcXU1lad
#T1D #diabetesResearch #postdoc #postdocposition @HelsinkiUniMed

[Vikash Chandra @Dr_V_Chandra]

I am grateful to @novonordiskfond for funding a project grant to understand the mechanism for differential vulnerability of alpha and beta cells in #T1D through stem cells islets; looking for a motivated #postdoc ! @HelsinkiUniMed @helsinkiuni #Type1diabetes

[the(sugar)science @thesugarscience]

🧬 Exciting new episode alert! 🧬

Join us as Vikash Chandra discusses potential candidate genes for drug targeting in #Type1Diabetes. Dive into groundbreaking insights and innovative research.

Watch now: https://t.co/Fy1MP2rPuf

#DiabetesResearch #DrugDiscovery #TSS

[the(sugar)science @thesugarscience]

Thursday! - 9 AM PT//12 PM ET
📢: https://t.co/tzjMJF13NB
@DiabetesnPOD @ULBCDiabRes @AMP_CMDKP
@ufdiabete @IUSweetTweets @T1D_researchers
@helmholtz_diabc @PennIDOM
@DiabResearch @Diabetes_DRI @StanfordDRC
@BCDiabResNet @JoslinDiabetes @Bruskolab
@helsinkiuni @Dr_V_Chandra

[Timo Otonkoski @OtonkoskiT]

Very happy to see our long-term project on the functional characterization of an RFX6 mutation enriched in Finns published in @DiabetologiaJnl. Superb work by @Hazemibrahimi. Read here: https://t.co/jtAVxH69x9

[EISG 2025 @eisg2025]

We're thrilled to announce that #EISG24_Helsinki 🇫🇮 is now SOLD OUT! 📷 Get ready for an exciting week of islet biology! We apologize to those who missed out, please register to the waiting list. We will consider the possibility of virtual attendance: https://t.co/mLJa4llgoF

[EISG 2025 @eisg2025]

Register now to the European Islet Study Group meeting in Helsinki, Finland, 18-20 June 2024 🚨Early-bird registration and abstract deadline is approaching, do not miss your chance, limited seats availablea and they are quickly filling up! https://t.co/pTXSXMMl0u…Please RT ;)

[EISG 2025 @eisg2025]

Thrilled to announce that registration and abstract submission for European Islet Study Group meeting in Helsinki, Finland, 18-20 June 2024 is NOW OPEN! https://t.co/kk5ealxGZS
🚨Early-bird registration is March 15th, limited seats available🚨
Please RT ;)

[ISRO @isro]

LVM3 M4/Chandrayaan-3 Mission:
LVM3 M4 vehicle🚀 successfully launched Chandrayaan-3🛰️ into orbit.

[Aaron Scott @AaronJonScott]

I love a muscle image, but this Drosophila one is top of the class! Beautiful

Fly muscles https://t.co/gTVWaHhlnv @andor

[Vikash Chandra @Dr_V_Chandra]

Great to present our latest research by Sophia at 19th Immunology of Diabetes Society #IDS #Paris 23 conference #T1d #Diabetes #Immunology @OtonkoskiL @Innodiagroup @HelsinkiUniMed @OtonkoskiT

[Vikash Chandra @Dr_V_Chandra]

Our research topic "Revisiting cellular metabolism and Type1 diabetes" is now online in @FrontEndocrinol https://t.co/si1kTcjlTI
with @SwethaGopalakr2 and Latif Rachdi

[Medicine and Health, University of Helsinki @HelsinkiUniMed]

According to a study @helsinkiuni, type 1 diabetes could be prevented by inhibiting a gene associated with the onset of the disease. @OtonkoskiL @OtonkoskiT @Dr_V_Chandra #WorldDiabetesDay https://t.co/fS7LatGsGf

[Medical Xpress @medical_xpress]

A promising drug candidate discovered for the prevention of type 1 #diabetes @helsinkiuni @NatureComms https://t.co/evtEA69diB https://t.co/TaqnU9fMH8

[Hazem Ibrahim @Hazemibrahimi]

Our article is featured in the top 50 of the stem cells category @NatureComms

https://t.co/wEioRiBinM

[Yle Uutiset @yleuutiset]

Helsinkiläistutkijoilta hyviä uutisia tyypin 1 diabetesta sairastaville – lääke ehkä löydetty https://t.co/di2IoUhFKB

[Vikash Chandra @Dr_V_Chandra]

@johncallinan9 @OtonkoskiT @Hazemibrahimi @Innodiagroup BMS-986165

[Taneli Raivio @RaivioTaneli]

Kantasolututkimus paljastaa uuden palan diabeteksen mysteeripalapelistä! Voisiko TYK2 inhibiittori olla tyyppi 1 diabeteksen tulevaisuuden hoito?! Congrats Otonkoski-group! New avenues to treat type 1 diabetes! @HUS_fi @HelsinkiUniMed @Laakarilehti @DuodecimFi

[Vikash Chandra @Dr_V_Chandra]

Also on a brief note, feeling extremely honoured to be awarded docentship in experimental endocrinology from @HelsinkiUniMed Thanks to my mentor @OtonkoskiT and @OtonkoskiL for all the support 🙏

[Vikash Chandra @Dr_V_Chandra]

Glad to present our work TYK2 inhibition as a potential therapeutic target to halt #T1D progression. @OtonkoskiT @Hazemibrahimi @STEMMProgram @MetaStem_Center @helsinkiunimed @Innodiagroup @OtonkoskiL @NatureComms https://t.co/kGY7EYZLuc